干扰素调节因子家族的表达及其在急性髓性白血病的预后价值
Jiawei Zeng1,2,3,4, Jingwei Yao2,3, Yong Zhou2,3
1The School of Clinical Medicine, Fujian Medical University, Fuzhou, 351002, China.
Future oncology (London, England)
|December 6, 2023
概括
干扰素调节因子 (IRF) 基因表达在急性髓性白血病 (AML) 中不同. 高IRF1,IRF7和IRF9表达与更差的存活率相关,表明AML的潜在治疗点.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 急性髓性白血病 (AML) 是一种异质的血液性恶性瘤.
- 干扰素调节因子 (IRF) 在免疫反应和细胞分化中起着至关重要的作用.
- 在AML病原和预后中IRF家族基因的特定作用仍然不完全理解.
研究的目的:
- 调查干扰素调节因子 (IRF) 家族基因在急性髓性白血病 (AML) 中的临床病理学意义和预后价值.
主要方法:
- 在多个公共数据库中利用差异性基因表达分析.
- 进行了生存分析,以将IRF基因表达与患者的结果相关联.
- 使用诊断为AML的患者的临床数据验证的发现.
主要成果:
- 在AML患者中观察到IRF1,IRF2,IRF4,IRF5,IRF7,IRF8和IRF9表达的升调.
- 在AML中注意到IRF3和IRF6表达的下调.
- 增加IRF1,IRF7和IRF9的表达与AML的整体存活率较差显著相关.
结论:
- 过度表达IRF1,IRF7和IRF9可能是急性髓性白血病预后不佳的指标.
- IRF基因家族代表了AML治疗中新的治疗策略的潜在途径.
相关概念视频
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
01:28Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K